| Similar Articles |
|---|
 |
American Family Physician
July 15, 2000
Anthony F. Jerant |
Early Detection and Treatment of Skin Cancer The incidence of skin cancer is increasing by epidemic proportions...   |
American Family Physician
July 15, 2005
Rager, Bridgeford & Ollila |
Cutaneous Melanoma: Update on Prevention, Screening, Diagnosis, and Treatment Melanoma is an increasingly common malignancy, and it affects a younger population than most cancers. Selective screening by physicians ultimately may be most effective at preventing the advance of the disease. |
American Family Physician
November 15, 2000
Richard L. Edman & Jonathan T. Wolfe |
Prevention and Early Detection of Malignant Melanoma In addressing the problem of malignant melanoma, family physicians should emphasize primary prevention... |
Nurse Practitioner
April 2009
Randy M. Gordon |
Skin cancer: More than skin deep Skin cancer is the most common carcinoma in the United States, affecting millions. One in five Americans and one in three whites will develop skin cancer in their lifetime. |
Nursing Management
June 2009
Zimmerman & Britton |
Prevention Through Vigilance: Malignant Melanoma Management Nurses can play a critical role in the care of patients with melanoma by offering preventive education and support. |
American Family Physician
October 15, 2004
Stulberg, Crandell & Fawcett |
Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinomas Rates of squamous cell and basal cell carcinomas have been increasing. Primary care physicians can expect to diagnose six to seven cases of basal cell carcinoma and one to two cases of squamous cell carcinoma each year. |
American Family Physician
December 15, 2002
Lecia M. Apantaku |
Breast-Conserving Surgery for Breast Cancer Surgical treatment of breast cancer has changed significantly in recent years. The preferred method of treatment for many women with early breast cancer is conservative surgical therapy. |
American Family Physician
October 1, 2002
Canavan & Cohen |
Vulvar Cancer Vulvar cancer was reported in 3,200 women in 1998, resulting in 800 deaths. Recent evidence suggests that vulvar cancer comprises two separate diseases. |
American Family Physician
September 1, 2000 |
Photo Quiz Friable Neoplasm During Pregnancy |
American Family Physician
November 15, 2003
Stulberg et al. |
Common Hyperpigmentation Disorders in Adults Part II: Melanoma... Seborrheic Keratoses... Acanthosis Nigricans... Melasma... Diabetic Dermopathy... Tinea Versicolor... Postinflammatory Hyperpigmentation |
American Family Physician
February 15, 2003 |
Common Benign Skin Tumors Procedures for identifying and treating benign skin tumors. |
American Family Physician
May 1, 2002
Thomas J. Zuber |
Dermal Electrosurgical Shave Excision The dermal electrosurgical shave excision is a fast and inexpensive method of removing epidermal and dermal lesions. The procedure is ideally suited for pedunculated lesions raised above the level of the surrounding skin... |
American Family Physician
November 15, 2000 |
How to Prevent Melanoma Melanoma is a kind of skin cancer. It is sometimes called malignant melanoma. Melanoma is becoming more common every year. This is a very serious kind of skin cancer that can cause death.... |
American Family Physician
April 1, 2001 |
Melanoma What is melanoma?... Who gets melanoma?... Where do melanomas occur?... What does a melanoma look like?... |
American Family Physician
March 15, 2002
Thomas J. Zuber |
Punch Biopsy of the Skin Skin biopsy is one of the most important diagnostic tests for skin disorders. Punch biopsy is considered the primary technique for obtaining diagnostic full-thickness skin specimens. It requires basic general surgical and suture-tying skills and is easy to learn... |
American Family Physician
September 1, 2006 |
Melanoma: A Type of Skin Cancer Melanoma is a type of skin cancer. Most other skin cancers don't spread, but melanoma can spread through the whole body. If it is found early, it can be cured. |
American Family Physician
May 15, 2004
Mark D. Andrews |
Cryosurgery for Common Skin Conditions Cryosurgery is a highly effective treatment for a broad range of benign skin problems. With appropriate instruction and supervised experience, family physicians can master the technique quickly. |
American Family Physician
October 1, 2002
Hainer & Usatine |
Electrosurgery for the Skin The purposes of electrosurgery are to destroy benign and malignant lesions, control bleeding, and cut or excise tissue. The major modalities in electrosurgery are electrodesiccation, fulguration, electrocoagulation, and electrosection. |
American Family Physician
June 15, 2002
George J. Bitar |
Basal Cell Nevus Syndrome: Guidelines for Early Detection Basal cell nevus syndrome is an autosomal dominant condition with complete penetrance and variable expressivity. It is characterized by five major components. |
Chemistry World
January 13, 2015
Jennifer Newton |
Infrared offers odds on skin cancer spreading Scientists in Belgium have shown that infrared spectrometry can help predict how likely it is that a melanoma tumor, the deadliest form of skin cancer, has spread to other organs. |
Chemistry World
November 11, 2015
Maria Burke |
Viral cancer therapy approved in the US The first virus therapy to target cancer has been approved in the US. Its main target will be melanoma, the most aggressive form of skin cancer. |
Nursing
March 2010
Peg Gray-Vickrey |
Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice. |
BusinessWeek
May 27, 2010
Pettypiece & Gibson |
Training the Immune System to Fight Cancer Bristol-Myers' new melanoma drug may be a "game changer." |
HHMI Bulletin
Nov 2010
Amy Maxmen |
Driving the Immune System to Attack Cancer A researcher's longtime efforts to drive T cells to attack tumors hits pay dirt. |
The Motley Fool
July 15, 2008
Brian Orelli |
Will a New Use Help Schering-Plough's Near-Blockbuster Drug? Delaying relapses probably won't be enough to get its Pegintron approved as a treatment for melanoma. |
HHMI Bulletin
Aug 2011
Richard Saltus |
T-Cell Booster Kits A bioengineer remodels cell surfaces to prod the immune system. |
The Motley Fool
September 30, 2010
Brian Orelli |
Bristol-Myers' Delayed Steal ZymoGenetics price tag looks more reasonable. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
Cancer: On Target Once More Over the past year or two, a handful of Phase III failures, including megablockbusters like Avastin and Sutent in trials for all kinds of common tumors, indicate that targeted therapy is generally a blunt instrument. |
The Motley Fool
June 23, 2009
Brian Orelli |
Wonder Drug! Maybe? Get the facts before jumping on this one. |
American Family Physician
October 1, 2000
Gary A. Ratkin, M.D. |
Book Review Current Therapy in Cancer By John F. Foley, Julie M. Vose and James O. Armitage contains useful sections and chapters, but other texts provide this information in a more consistent style... |
The Motley Fool
September 14, 2011
Frank Vinluan |
Here's How New Roche Cancer Drug Zelboraf Benefits LabCorp A new Roche cancer drug expected to become a blockbuster could also end up being a boon for laboratory and diagnostics firm LabCorp. |
The Motley Fool
August 29, 2011
Brian Orelli |
Drug Approved for Few Patients -- but That's OK The age of personalized medicine is upon us. Earlier this month, the FDA approved Roche's melanoma drug Zelboraf for patients with a specific mutation in BRAF. And on Friday, the agency approved Pfizer's Xalkori for lung cancer patients that are ALK-positive. |
Pharmaceutical Executive
November 1, 2014
Josh Baxt |
2015 Pipeline Report: Burning Bright The science of drug discovery is back on script and the stars are cued up for a new generation of breakthrough therapies. |
Chemistry World
June 12, 2014
Andy Extance |
Pharma vies to unleash immune system power on cancer Drug firms are investing heavily in clinical trials and collaborations as they seek to capitalize on the potential of cancer therapies that enlist or enhance our immune systems' ability to fight tumors. |
The Motley Fool
May 9, 2007
Mike Havrilla |
Scintillating Synta Patient investors should peek at this pharma's promising pipeline. |
AskMen.com
Joshua Levine |
Skin Cancer And The Sun In 1998, the estimated new skin cancer cases in the U.S. were 30% more amongst men than women, and accounted for 50% more deaths for men. |
The Motley Fool
May 24, 2010
Brian Orelli |
ASCO Abstracts -- Pops and Drops! Ever since The American Society of Clinical Oncology began posting abstracts on-line -- and before that when they were sent to attendees -- investors have clamored to get a glimpse at the data. Here's your glimpse. |
Chemistry World
March 4, 2011
Elinor Richards |
Laser treatment for late-stage cancer Scientists from China, the US and Peru claim to have successfully treated late-stage breast cancer patients using laser immunotherapy to stimulate patients' own immune systems to fight the cancer. |
The Motley Fool
June 29, 2011
Brian Orelli |
4 Immunotherapies to Watch Just don't go all-in. |
Pharmaceutical Executive
June 9, 2014 |
Immunotherapies: The New Hope for Cancer Treatment The Cancer Research Institute is clearing a path to the future of immunotherapeutics. Ben Comer speaks to its CEO and director of scientific affairs, Jill O'Donnell-Tormey |
The Motley Fool
June 7, 2010
Brian Orelli |
Bristol Investors Go Crazy Wild. Are They Justified? Bristol-Myers Squibb is up a lot on an upgrade and some positive data coming out of the American Society of Clinical Oncology meeting, but investors need to be careful. |
Scientific American
January 2009
Charles Q. Choi |
Do White Blood Cells Make Cancer Deadly? The ability to spread underlies the killing power of cancer. The process occurs, John Pawelek thinks, when tumor cells fuse with white blood cells -- an idea that, if right, could yield new therapies |
The Motley Fool
April 19, 2004
Charly Travers |
4 Promising Biotech IPOs Several recently gone-public biotechs boast surprisingly interesting drug pipelines. From drugs for hepatitis to hopeful cancer treatments, watch out for these four biotech debutantes. If trials go smoothly, they may be the next up-and-coming stocks in the industry. |
The Motley Fool
April 28, 2009
Brian Orelli |
Headline? Bad! Unexpected? No! For a company that only has one drug on the market, stopping a failing phase 3 clinical trial that's designed to expand the market of that drug is usually a major blow. But Onyx Pharmaceuticals was able to shrug it off. |
American Family Physician
September 1, 2006 |
Checking Yourself for Signs of Skin Cancer It's a good idea to check your skin each month for signs of skin cancer. The sooner skin cancer is found, the greater the chance that it can be cured. |
The Motley Fool
May 13, 2004
Charly Travers |
Avoiding Biotech Land Mines Successful biotech investing depends upon not getting caught up in bad situations. Lessons learned from these case studies can help us from getting trapped in similar situations in the future. |
